Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) has been given a consensus recommendation of “Buy” by the seven ratings firms that are presently covering the company, Marketbeat.com reports. Seven investment analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have updated their coverage on the stock […]
Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) has earned an average rating of “Buy” from the seven ratings firms that are covering the stock, Marketbeat.com reports. Seven research analysts have rated the stock with a buy rating. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the […]
Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) have been given a consensus rating of “Buy” by the seven research firms that are covering the company, MarketBeat reports. Seven analysts have rated the stock with a buy recommendation. The average 1-year target price among brokers that have updated their coverage on the stock […]
Decheng Capital LLC Acquires New Shares in Pyxis Oncology, Inc. (NASDAQ:PYXS) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Pyxis Oncology (NASDAQ:PYXS) Releases Earnings Results, Beats Estimates By $0.19 EPS tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.